Ardelyx Inc $ARDX

Recent News (5)

• Ardelyx to Participate in Upcoming Investor Conferences GlobeNewswire · 01 Sep 2026 WALTHAM, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercializa…
• Ardelyx chief patient officer sells $41,419 in stock Investing.com · 26 Aug 2026 Ardelyx chief patient officer sells $41,419 in stock
• Ardelyx SVP Joseph Reilly sells $15,358 of company stock Investing.com · 25 Aug 2026 Ardelyx SVP Joseph Reilly sells $15,358 of company stock
• Ardelyx chief technical officer John Bishop sells $76,173 in stock Investing.com · 25 Aug 2026 Ardelyx chief technical officer John Bishop sells $76,173 in stock
• Ardelyx chief human resources officer sells $58,378 in stock Investing.com · 25 Aug 2026 Ardelyx chief human resources officer sells $58,378 in stock